Park Dental Partners, Inc. (NASDAQ: PARK) announced its financial results for the third quarter of 2026, reporting a 6.0% increase in revenue to $64.9 million. This figure compares to $61.3 million in the prior-year period. For the first nine months of 2026, total revenue reached $193.8 million, representing a 5.8% increase over the same period in 2025.
The company reported a net income of $1.7 million, or $0.27 per diluted share, for the third quarter of 2026. This compares to $1.3 million, or $0.72 per diluted share, in the third quarter of 2025. For the first nine months of 2026, net income was $2.7 million, or $0.43 per diluted share, down from $5.4 million, or $3.06 per diluted share, in the prior year.
Adjusted EBITDA for the third quarter of 2026 was $5.0 million, with an adjusted diluted earnings per share of $0.57. For the first nine months, Adjusted EBITDA was $17.1 million, and adjusted diluted EPS was $1.68. The company noted that gross margin was impacted by higher salaries and benefits, including doctor share-based compensation associated with its transition to a public company.
As of September 30, 2026, Park Dental supported 88 affiliated practices and 225 affiliated doctors. Patient visits increased to 180,955 across the network, and the patient retention rate was 90.2%. During the quarter, the company completed the acquisition of Village Family DSO, a multi-specialty dental group based in Fayetteville, North Carolina. The acquisition extends the company's network into a fourth state.
On the balance sheet, cash and cash equivalents totaled $23.2 million as of September 30, 2026. Total debt outstanding was approximately $10.6 million, with a $15 million line of credit remaining undrawn. The company generated $12.0 million in operating cash flow during the first nine months of 2026.
Regarding the full year 2026 outlook, Park Dental expects revenue between $262.0 million and $265.0 million. The company anticipates Adjusted EBITDA between $21.2 million and $22.2 million, with a margin of 8.1% to 8.4%. The outlook incorporates the expected contribution from the recently acquired Village Family DSO and reflects increased investments in clinical capacity.
